Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in JapanHemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingNot stated2026-01-02NCT05228158

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Eisai Co., Ltd.15

135 results · Page 1 of 6

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Eisai Trial Site 1Chuo-kuJapan2
Eisai Trial Site 101TokushimaJapan1
Eisai Trial Site 105TakamatsuJapan1
Eisai Trial Site 106NagoyaJapan1
Eisai Trial Site 107Edogawa-kuJapan1
Eisai Trial Site 109Ebina-shiJapan1
Eisai Trial Site 118KagoshimaJapan1
Eisai Trial Site 119ChibaJapan1
Eisai Trial Site 12OkayamaJapan1
Eisai Trial Site 122Matsusaka-shiJapan1
Eisai Trial Site 124Itami-shiJapan1
Eisai Trial Site 125Ogaki-shiJapan1
Eisai Trial Site 127NagasakiJapan1
Eisai Trial Site 130ToyohashiJapan1
Eisai Trial Site 131Komaki-shiJapan1
Eisai Trial Site 133Toyota-shiJapan1
Eisai Trial Site 134Iizuka-shiJapan1
Eisai Trial Site 14OkayamaJapan1
Eisai Trial Site 140Tokorozawa-shiJapan1
Eisai Trial Site 142Tanabe-shiJapan1
Eisai Trial Site 144OsakaJapan1
Eisai Trial Site 148Hidaka-shiJapan1
Eisai Trial Site 152Saitama-shiJapan1
Eisai Trial Site 156NagoyaJapan1
Eisai Trial Site 158Bunkyo-kuJapan1